Medicina Aparato Digestivo. Unidad de Endoscopia, Hospital Universitario 12 de Octubre, España.
Medicina Aparato Digestivo. Unidad de Endoscopia, Hospital Universitario 12 de Octubre.
Rev Esp Enferm Dig. 2020 Mar;112(3):189-194. doi: 10.17235/reed.2020.6239/2019.
endoscopic submucosal dissection for gastric lesions (ESD-G) is a technique that allows en-bloc resection of early gastric tumors, with a cure rate similar to that of surgery but lower morbidity and mortality rates.
to assess total survival, disease-free survival and relapse rate during the course of disease in a Spanish cohort of patients undergoing ESD-G.
this was a prospective observational study of patients undergoing ESD-G from 2008 to 2015, with a follow-up ranging from six to 60 months. Recurrence at five years was analyzed using Kaplan-Meier curves and the results were compared according to several factors using the log-rank test. These included en-bloc versus piecemeal resection and R0 curative resection versus resection with affected lateral margins (LM+).
a total of 35 patients undergoing ESD-G were assessed, with a median follow-up of 33.62 months. Four relapses were identified (11.4%) during this period, of which three were managed with repeat ESD-G. A histological specimen with LM+ was associated with a higher local relapse rate during follow-up (p = 0.06). Piecemeal resections had a higher relapse risk, although no statistically significant differences were identified (p = 0.49). No deaths from gastric cancer occurred and no gastrectomies due to persistent disease were performed during this period. The overall survival rate in our series was 94.3%.
ESD-G in our setting provides high long-term cure rates, while avoiding surgery. These results are similar to those reported by the European series and remain far removed from the cure and relapse rates obtained in Asian cohorts. Local relapse cases may be monitored with endoscopy.
内镜黏膜下剥离术(ESD)用于治疗胃部病变,能够整块切除早期胃部肿瘤,其治愈率与手术相当,但并发症和死亡率更低。
评估西班牙患者接受 ESD-G 治疗后,总生存率、无病生存率和疾病复发率。
这是一项前瞻性观察性研究,纳入了 2008 年至 2015 年期间接受 ESD-G 治疗的患者,随访时间为 6 至 60 个月。采用 Kaplan-Meier 曲线分析 5 年复发率,并使用对数秩检验根据多个因素(整块切除与分片切除,R0 根治性切除与边缘受累的切除)比较结果。
共评估了 35 例接受 ESD-G 的患者,中位随访时间为 33.62 个月。在此期间,有 4 例患者(11.4%)复发,其中 3 例接受了再次 ESD-G 治疗。组织学标本存在边缘受累与随访期间局部复发率较高相关(p = 0.06)。分片切除的复发风险较高,但无统计学差异(p = 0.49)。在此期间,无胃癌死亡病例,也无需进行胃切除术以治疗持续性疾病。我们的系列研究中,总生存率为 94.3%。
在我们的研究中,ESD-G 能够提供长期高治愈率,同时避免手术。这些结果与欧洲系列研究相似,远高于亚洲队列的治愈率和复发率。局部复发病例可以通过内镜监测。